Home kits often lack pharmaceutical-grade purity and precise clinical dosage control, significantly increasing the risk of adverse health effects.
P.MeisterA
The 2025/2026 Lactation Studies: Recent clinical trials completed in late 2025 have been very encouraging
Watch for this common mistake
Book a FREE 15-minute consultation to see if switching to Tirzepatide is right for you Sources: 1 Aronne, L
A randomized, parallel-group, multicenter, phase 3 trial found that tirzepatide caused pancreatitis (5 mg n = 3, 10 mg n = 2, 15 mg n = 1) in patients with type 2 diabetes mellitus (Del Prato et al., 2021), and another double-blind, randomized, multicenter, phase 3 trial found that tirzepatide also caused pancreatitis (15 mg n = 2) in obese patients with type 2 diabetes mellitus (Garvey et al., 2023)